| Product NDC: | 0095-0073 |
| Proprietary Name: | HYLASE Wound |
| Non Proprietary Name: | Sodium Hyaluronate |
| Active Ingredient(s): | 2.5 g/100g & nbsp; Sodium Hyaluronate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0095-0073 |
| Labeler Name: | ECR Pharmaceuticals Co., Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20120106 |
| Package NDC: | 0095-0073-75 |
| Package Description: | 1 TUBE in 1 CARTON (0095-0073-75) > 75 g in 1 TUBE |
| NDC Code | 0095-0073-75 |
| Proprietary Name | HYLASE Wound |
| Package Description | 1 TUBE in 1 CARTON (0095-0073-75) > 75 g in 1 TUBE |
| Product NDC | 0095-0073 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sodium Hyaluronate |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20120106 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | ECR Pharmaceuticals Co., Inc. |
| Substance Name | HYALURONATE SODIUM |
| Strength Number | 2.5 |
| Strength Unit | g/100g |
| Pharmaceutical Classes |